Dose intensified preoperative chemotherapy with doxorubicin/docetaxel in operable breast cancer - A phase II trial

被引：0
|
作者：
Blohmer, JU
Tulusan, AH
Jackisch, C
Kaufmann, M
Costa, SD
von Minckwitz, G
Eiermann, W
机构：
[1] Univ Frankfurt, Womens Hosp, D-6000 Frankfurt, Germany
[2] Univ Munster, Womens Hosp, D-4400 Munster, Germany
[3] Univ Bayreuth, Womens Hosp, Bayreuth, Germany
[4] Univ Bern, Womens Hosp, Berlin, Germany
[5] Rot Kreuz Krh, Munich, Germany
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
33P
引用
收藏
页码：7 / 7
页数：1
相关论文
共 50 条
  • [21] First-line chemotherapy of advanced or metastatic breast cancer (MBC) with docetaxel and doxorubicin in Indonesia: results from A phase II trial
    Abdulmuthalib
    Darwis, Idral
    Prayogo, Nugroho
    Sutjipto
    MEDICAL JOURNAL OF INDONESIA, 2005, 14 (01) : 20 - 25
  • [22] Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer
    Bhuvaneswari Ramaswamy
    Steven P Povoski
    Chris Rhoades
    Joan Allen
    Marsha Hauger
    Donn Young
    William Burak
    William Farrar
    Lisa Yee
    Kari Kendra
    Sivagurunathan Somasundaram
    Robert Z Orlowski
    Charles L. Shapiro
    Breast Cancer Research and Treatment, 2005, 93 : 67 - 74
  • [23] Phase II trial of neoadjuvant chemotherapy with docetaxel followed by epirubicin in stage II/III breast cancer
    Ramaswamy, B
    Povoski, SP
    Rhoades, C
    Allen, J
    Hauger, M
    Young, D
    Burak, W
    Farrar, W
    Yee, L
    Kendra, K
    Somasundaram, S
    Orlowski, RZ
    Shapiro, CL
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 93 (01) : 67 - 74
  • [24] A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer
    Jeon, Ye Won
    Kim, Tae Hyun
    Youn, Hyun Jo
    Han, Sehwan
    Jung, Yongsik
    Gwak, Geumhee
    Park, Young Sam
    Kim, Jeong Soo
    Suh, Young Jin
    JOURNAL OF BREAST CANCER, 2017, 20 (04) : 340 - 346
  • [25] Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer
    Guarneri, Valentina
    Frassoldati, Antonio
    Ficarra, Guido
    Jovic, Gordana
    Puglisi, Fabio
    Michelotti, Andrea
    Boni, Corrado
    Battelli, Nicola
    Santoro, Armando
    Conte, PierFranco
    ANNALS OF ONCOLOGY, 2006, 17 : 93 - 93
  • [26] Phase II study of concurrent administration of doxorubicin and docetaxel as first-line chemotherapy for metastatic breast cancer
    Aihara, T
    Takatsuka, Y
    Itoh, K
    Sasaki, Y
    Katsumata, N
    Watanabe, T
    Noguchi, S
    Horikoshi, N
    Tabei, T
    Sonoo, H
    Hiraki, S
    Inaji, H
    ONCOLOGY, 2003, 64 (02) : 124 - 130
  • [27] Phase-III trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide for primary breast cancer
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (04) : 253 - 254
  • [28] Phase I trial of dose-dense docetaxel and doxorubicin with or without sargramostim in patients with metastatic breast cancer
    Montero A.
    Booser D.
    Esparza-Guerra L.
    Murray J.
    Rosales M.
    Hortobagyi G.
    Valero V.
    Drugs in R & D, 2005, 6 (5) : 299 - 305
  • [29] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee, Keun Seok
    Ro, Jungsil
    Nam, Byung-Ho
    Lee, Eun Sook
    Kwon, Youngmee
    Kwon, Hye Soo
    Chung, Ki Wook
    Kang, Han Sung
    Kim, Eun A.
    Kim, Seok Won
    Shin, Kyung Hwan
    Kim, Seok-Ki
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 481 - 489
  • [30] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Keun Seok Lee
    Jungsil Ro
    Byung-Ho Nam
    Eun Sook Lee
    Youngmee Kwon
    Hye Soo Kwon
    Ki Wook Chung
    Han Sung Kang
    Eun A Kim
    Seok Won Kim
    Kyung Hwan Shin
    Seok-Ki Kim
    Breast Cancer Research and Treatment, 2008, 109 : 481 - 489
12345